You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫思健康(02138.HK)擬先舊後新配股淨籌2.488億港元
格隆匯 07-09 06:30

格隆匯7月9日丨醫思健康(02138.HK)發佈公吿,2021年7月8日,公司、Union Medical Care Holding Limited(作為賣方)及海通國際證券(作為配售代理)訂立該協議,據此,賣方同意委任配售代理,促使買方按配售價每股14.50港元購買合共約2797.24萬股現有股份;及公司同意按認購價(與配售價相同)向賣方配發及發行合共約1721.38萬股新股份。

預期配售股份將配售予鄭志剛(以個人名義投資)及Aspex MasterFund。賣方為集團主席兼執行董事鄧志輝全資擁有的公司。於該公吿日期,賣方為公司控股股東,持有721,231,230股股份,相當於公司現有已發行股本約64.99%。由於配售事項,賣方的總股權百分比將由約65.83%減少至約63.31%,而由於認購事項,賣方的總股權百分比將由約63.31%增加至約63.87%。配售股份相當於該公吿日期已發行股份總數約2.52%及經擴大已發行股份總數約2.48%。配售價每股14.50港元較該協議日期收市價14.94港元折讓約2.95%。

假設所有配售股份獲悉數配售予買方及認購股份獲悉數認購,所得款項淨額估計約為2.488億港元,相當於淨髮行價每股配售股份及每股認購股份約14.46港元。公司擬將配售事項及認購事項所得款項淨額悉數用於擴大集團於中國香港及中國大灣區的診所網絡、併購及集團的一般企業用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account